Home/Pipeline/BIT225

BIT225

HIV‑1

Phase 2Active

Key Facts

Indication
HIV‑1
Phase
Phase 2
Status
Active
Company

About Biotron

Australian‑stage antivirals targeting viroporins to treat HIV, HCV and emerging viral diseases.

View full company profile

About Biotron

Australian‑stage antivirals targeting viroporins to treat HIV, HCV and emerging viral diseases.

View full company profile

About Biotron

Australian‑stage antivirals targeting viroporins to treat HIV, HCV and emerging viral diseases.

View full company profile

Therapeutic Areas